stockrowElanco Animal Health Incorporated
ELAN Healthcare Drug Manufacturers Specialty & Generic
Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.
- Revenue
- +10.2%
- EPS
- +450.0%
- Free cash flow
- +35.6%
- Total debt
- −6.91%
Quarter to June 2026, against a year earlier
Follow ELAN
Alert me
Elanco Animal Health Incorporated (ELAN) Return on assets
Elanco Animal Health Incorporated's return on assets over the twelve months to 30 June 2026 was −1.46%, up 0.3 percentage points from fiscal 2025 (−1.79%). Over the past ten years it has ranged from −8.25% (fiscal 2023) to 2.51% (fiscal 2024); the current reading is higher than 55% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of −1.67% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −1.79% | (4.30) |
| FY2024 | 2.51% | 10.76 |
| FY2023 | −8.25% | (7.76) |
| FY2022 | −0.49% | 2.34 |
| FY2021 | −2.83% | 1.47 |
| FY2020 | −4.30% | (5.06) |
| FY2019 | 0.76% | (0.21) |
| FY2018 | 0.97% | 4.62 |
| FY2017 | −3.65% | (2.47) |
| FY2016 | −1.18% | 4.03 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 14.2% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 12.9% |
| LNTH Lantheus Holdings, Inc. compare | 11.4% |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.44% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 3.01% |
| ALKS Alkermes plc compare | −0.01% |
| ELAN Elanco Animal Health Incorporated | −1.46% |
| VTRS Viatris Inc. compare | −1.67% |
| HIMS Hims & Hers Health, Inc. compare | −5.16% |
| Drug Manufacturers Specialty & Generic industry median | −1.67% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on ELAN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement